[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20073333L - Nye farmasoytiske sammensetninger for vaksiner - Google Patents

Nye farmasoytiske sammensetninger for vaksiner

Info

Publication number
NO20073333L
NO20073333L NO20073333A NO20073333A NO20073333L NO 20073333 L NO20073333 L NO 20073333L NO 20073333 A NO20073333 A NO 20073333A NO 20073333 A NO20073333 A NO 20073333A NO 20073333 L NO20073333 L NO 20073333L
Authority
NO
Norway
Prior art keywords
vaccines
pharmaceutical compositions
new pharmaceutical
vaccine
relates
Prior art date
Application number
NO20073333A
Other languages
English (en)
Inventor
Marinette Moreau
Nicolas Osty
Original Assignee
Vetoquinol Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetoquinol Sa filed Critical Vetoquinol Sa
Publication of NO20073333L publication Critical patent/NO20073333L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

Farmasøytiske preparater, spesielt innen vaksineområdet. Mer spesielt angår oppfinnelsen et farmasøytisk preparat som er nyttig som vaksine (eller vaksinepreparat). Oppfinnelsen angår også en fremgangsmåte for fremstilling av oppfinnelsens vaksinepreparat.
NO20073333A 2004-12-02 2007-06-28 Nye farmasoytiske sammensetninger for vaksiner NO20073333L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0452838A FR2878746B1 (fr) 2004-12-02 2004-12-02 Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins
PCT/FR2005/002995 WO2006059009A1 (fr) 2004-12-02 2005-12-01 Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins

Publications (1)

Publication Number Publication Date
NO20073333L true NO20073333L (no) 2007-08-17

Family

ID=34952132

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073333A NO20073333L (no) 2004-12-02 2007-06-28 Nye farmasoytiske sammensetninger for vaksiner

Country Status (17)

Country Link
US (1) US8158133B2 (no)
EP (1) EP1817053A1 (no)
JP (1) JP4987725B2 (no)
KR (1) KR20070106988A (no)
CN (1) CN101111262A (no)
AU (1) AU2005311188B2 (no)
BR (1) BRPI0517124A (no)
CA (1) CA2589841A1 (no)
EA (1) EA200701201A1 (no)
FR (1) FR2878746B1 (no)
IL (1) IL183518A (no)
MX (1) MX2007006521A (no)
NO (1) NO20073333L (no)
NZ (1) NZ555743A (no)
UA (1) UA91203C2 (no)
WO (1) WO2006059009A1 (no)
ZA (1) ZA200705079B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2851066A1 (en) * 2013-09-23 2015-03-25 LTS LOHMANN Therapie-Systeme AG Fixation of vaccine formulations on devices for epidermal immunisation by oily adjuvants

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US478056A (en) * 1892-06-28 Trustees
ZA872532B (en) 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
DE3867924D1 (de) * 1987-06-23 1992-03-05 Eniricerche Spa Ein-phasen-praeparat, das ein perfluoriertes oel und ein oder mehrere oberflaechenaktive stoffe enthaelt, verwendbar als hilfsstoff fuer kosmetische und dermatologische mittel sowie fuer biomedizinische anwendungen.
EP0398288B1 (de) 1989-05-16 1995-10-18 MEDICEChem.-Pharm. Fabrik Pütter GmbH & Co. KG Verfahren zur Herstellung optisch aktiver 2-Aryl-Alkansäuren, insbesondere von 2-Aryl-Propionsäuren
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
US5961970A (en) 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
US5744137A (en) * 1995-02-06 1998-04-28 The United States Of America As Represented By The Secretary Of The Agriculture Oil emulsion vaccines prepared with animal, vegetable, and synthetic oils using a mixture of nonionic surfactants
JP4104186B2 (ja) * 1995-11-30 2008-06-18 財団法人化学及血清療法研究所 オイルアジュバントワクチンおよびその調製方法
ES2277339T3 (es) * 1995-11-30 2007-07-01 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Vacuna con adyuvante de aceite y metodo para su preparacion.
EP0988858A1 (en) * 1997-04-18 2000-03-29 Taisho Pharmaceutical Co., Ltd Microemulsion
EP1469009A2 (en) * 1998-05-21 2004-10-20 Isis Parmaceuticals, Inc. Compositions and methods for non-parenteral delivery of oligonucleotides
US6919442B1 (en) * 1998-05-22 2005-07-19 The United States Of America As Represented By The Department Of Health And Human Services Nucleic acids comprising a post-transcriptional regulatory element (PRE) and their uses
PT1079807E (pt) 1998-05-27 2007-01-31 Euro Celtique Sa Preparações para aplicação de agentes anti inflamatórios, em especial de agentes antissépticos e/ou agentes que promovam a cicatrização de feridas, na parte inferior do aparelho respiratório
AU769539B2 (en) 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
JP4642950B2 (ja) 1999-03-04 2011-03-02 株式会社資生堂 メーキャップ除去用化粧料
JP4570705B2 (ja) * 1999-03-04 2010-10-27 株式会社資生堂 メーキャップ除去用化粧料
EP1104767A1 (en) 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
PT1322287E (pt) 2000-09-28 2006-08-31 Chiron Corp Microparticulas para a administracao de acidos nucleicos heterologos
ES2331058T3 (es) * 2001-02-28 2009-12-21 Intervet International Bv Emulsiones de agua en aceite inyectables.
CN1636015A (zh) 2001-06-29 2005-07-06 希龙公司 Hcv e1e2疫苗组合物
US20030119774A1 (en) 2001-09-25 2003-06-26 Marianna Foldvari Compositions and methods for stimulating an immune response
DK1613346T3 (da) * 2003-04-04 2013-01-07 Pah Usa 15 Llc Mikrofluidiske olie-i-vand-emulsioner og vaccinesammensætninger
US20060292186A1 (en) * 2003-08-29 2006-12-28 Novagali Pharma Sa Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs

Also Published As

Publication number Publication date
UA91203C2 (ru) 2010-07-12
CN101111262A (zh) 2008-01-23
ZA200705079B (en) 2008-08-27
AU2005311188A1 (en) 2006-06-08
EP1817053A1 (fr) 2007-08-15
IL183518A0 (en) 2007-09-20
IL183518A (en) 2011-09-27
KR20070106988A (ko) 2007-11-06
CA2589841A1 (fr) 2006-06-08
US8158133B2 (en) 2012-04-17
JP4987725B2 (ja) 2012-07-25
MX2007006521A (es) 2007-11-08
US20080026006A1 (en) 2008-01-31
EA200701201A1 (ru) 2007-10-26
AU2005311188B2 (en) 2011-07-07
JP2008521865A (ja) 2008-06-26
FR2878746A1 (fr) 2006-06-09
WO2006059009A1 (fr) 2006-06-08
FR2878746B1 (fr) 2007-02-23
BRPI0517124A (pt) 2008-09-30
NZ555743A (en) 2009-06-26

Similar Documents

Publication Publication Date Title
WO2017070620A3 (en) Broad spectrum influenza virus vaccine
MX2010008799A (es) Proceso para estabilizar una composicion de vacuna que contiene adyuvante.
WO2007024941A3 (en) Polyvalent vaccine
CY1118454T1 (el) Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες
TW200642700A (en) Chemically defined stabiliser
BR112012029517A2 (pt) formulações de fragrância, métodos de fabricação e artigos compreendendo as mesmas.
EA201070699A1 (ru) Композиции 3-(6-(1-2,2-дифторбензо[d][1,3]диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты
CY1115838T1 (el) Μεθοδος για τη σταθεροποιηση φαρμακοτεχνικων μορφων που περιεχουν μικροοργανισμους
EA201170772A1 (ru) Органические соединения
NO20084850L (no) MGLUR5 modulatorer I
CY1111367T1 (el) Νεα παραγωγα της διοσμετινης, η μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα περιεχουν
MX349119B (es) Vacuna de virus de dengue inactivado.
DK1810676T3 (da) Levetiracetam formuleringer og fremgangsmåder til deres fremstilling
WO2007136689A3 (en) Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
WO2009009759A3 (en) Yersinia pestis antigens, vaccine compositions, and related methods
ATE482194T1 (de) Indolonderivate, verfahren zu deren herstellung und deren anwendungen
CY1117288T1 (el) Παραγωγα 2-οξο-1-πυρρολιδινυλ ιμιδαζοθειαδιαζολης
EA201070689A1 (ru) Композиция для личного ухода
MY151211A (en) 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
NO20091990L (no) Substituerte pyrazoler, sammensetninger inneholdende disse, fremgangsmate for fremstilling og anvendelse
TW200718698A (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
BRPI0909737A2 (pt) compostos de pirrolidinila, composição farmacêutica compreendendo os mesmos e usos dos mesmos
WO2006063053A3 (en) Methods of producing influenza vaccine compositions
MX349563B (es) Formulacion farmaceutica de fenofibrato nanonizado.
NO20073046L (no) Utvalgte benzofuranderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application